These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6868024)

  • 21. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
    Walenga RW; Miller JL; Stuart MJ
    Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation.
    Túri S; Bereczki C; Torday C; Havass Z; Németh M
    Pediatr Nephrol; 1991 May; 5(3):327-31. PubMed ID: 1651098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet thromboxane synthesis in treated childhood diabetes mellitus.
    Davì G; Triolo G; Meli F; Cardella F; Giardina E
    Thromb Res; 1983 Dec; 32(5):469-77. PubMed ID: 6419383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet thromboxane formation and BTG levels after intensive charcoal HP in uremics or regular hemodialytic treatment (RHT).
    Capodicasa G; Daví G; Picone F; Mattina A; Giannetto V; Vinti V; Vaccaro F; Strano A; De Santo NG; Giordano C
    Int J Artif Organs; 1983 Jul; 6(4):183-6. PubMed ID: 6195116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanism of antiaggregatory effect of Moutan Cortex.
    Hirai A; Terano T; Hamazaki T; Sajiki J; Saito H; Tahara K; Tamura Y; Kumagai A
    Thromb Res; 1983 Jul; 31(1):29-40. PubMed ID: 6412397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbits.
    Dembińska-Kièć A; Rücker W; Schönhöfer PS
    Atherosclerosis; 1979 Jun; 33(2):217-26. PubMed ID: 224890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease.
    Matsumoto M; Kusunoki M; Uyama O; Fujisawa A; Matsuyama T; Yoneda S; Kimura K; Abe H
    Prostaglandins Med; 1981 Dec; 7(6):553-62. PubMed ID: 7323212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro effects of nafazatrom (Bay g 6575), an antithrombotic compound, on arachidonic acid metabolism in platelets and vascular tissue.
    Fischer S; Struppler M; Weber PC
    Biochem Pharmacol; 1983 Jul; 32(14):2231-6. PubMed ID: 6688182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets.
    Best LC; Jones PB; Russell RG
    Clin Sci (Lond); 1980 Aug; 59(2):131-5. PubMed ID: 7190885
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.
    Cerskus AL; Ali M; McDonald JW
    Thromb Res; 1980 Jun; 18(5):693-705. PubMed ID: 7414555
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane.
    McGoff MA; Allen BT; Der T; Sicard GA; Santoro SA
    Thromb Res; 1989 Sep; 55(6):695-707. PubMed ID: 2506670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of isosorbide dinitrate on platelet aggregation and production of thromboxane B2].
    De Caterina R; Crea F; Giannessi D; Bernini W; Gazzetti P; Chierchia S; Distante A; L'Abbate A
    Cardiologia; 1982; 27(3):315-7. PubMed ID: 6892461
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of fasting on production from exogenous arachidonic acid of thromboxane and 12-hydroxy 5, 8, 10, 14-Eicosatetraenoic acid (12-HETE) by washed platelets of normal and streptozotocin diabetic mice.
    Rosenblum WI; Ellis EF; Cockrell C
    Thromb Res; 1982 Dec; 28(6):713-9. PubMed ID: 7167879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.